These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1712215)

  • 1. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1.
    Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and immunogenic sites of HIV-2 glycoproteins.
    Chiodi F; Björling E; Samuelsson A; Norrby E
    Chem Immunol; 1993; 56():61-77. PubMed ID: 8452654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of four antibody-binding sites in the envelope proteins of simian immunodeficiency virus, SIVsm.
    Samuelsson A; Björling E; Putkonen P; Utter G; Chiodi F; Norrby E
    AIDS; 1993 Feb; 7(2):159-65. PubMed ID: 7682082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.
    de Wolf F; Meloen RH; Bakker M; Barin F; Goudsmit J
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1261-7. PubMed ID: 1710645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of antibody-dependent cellular cytotoxicity in sera from human immunodeficiency virus type 2-infected individuals.
    Von Gegerfelt A; Diaz-Pohl C; Fenyö EM; Broliden K
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):883-9. PubMed ID: 7504937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.
    Robert-Guroff M; Aldrich K; Muldoon R; Stern TL; Bansal GP; Matthews TJ; Markham PD; Gallo RC; Franchini G
    J Virol; 1992 Jun; 66(6):3602-8. PubMed ID: 1374810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination.
    McBride BW; Corthals G; Rud E; Kent K; Webster S; Cook N; Cranage MP
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1033-41. PubMed ID: 7685372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New multiple antigenic peptide-based enzyme immunoassay for detection of simian immunodeficiency virus infection in nonhuman primates and humans.
    Ndongmo CB; Switzer WM; Pau CP; Zeh C; Schaefer A; Pieniazek D; Folks TM; Kalish ML
    J Clin Microbiol; 2004 Nov; 42(11):5161-9. PubMed ID: 15528710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
    Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
    J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.
    Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity.
    Meloen RH; Liskamp RM; Goudsmit J
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1505-12. PubMed ID: 2471813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2.
    Björling E; Chiodi F; Utter G; Norrby E
    J Immunol; 1994 Feb; 152(4):1952-9. PubMed ID: 8120399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis and comparative analysis of antigenic activity of peptides from hypervariable region V3 of human immunodeficiency virus I gp120 surface glycoprotein].
    Semiletov IuA; Rzhaninova AA; Garaev MM
    Bioorg Khim; 1994 Oct; 20(10):1070-9. PubMed ID: 7826406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein.
    Javaherian K; Langlois AJ; Montefiori DC; Kent KA; Ryan KA; Wyman PD; Stott J; Bolognesi DP; Murphey-Corb M; Larosa GJ
    J Virol; 1994 Apr; 68(4):2624-31. PubMed ID: 7511176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.
    Böttiger B; Karlsson A; Andreasson PA; Nauclér A; Costa CM; Norrby E; Biberfeld G
    J Virol; 1990 Jul; 64(7):3492-9. PubMed ID: 2191152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
    Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J
    J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of B-cell antigenic sites on HIV-2 gp125.
    Mannervik M; Putkonen P; Rudén U; Kent KA; Norrby E; Wahren B; Broliden PA
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):177-87. PubMed ID: 1370692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictions of linear T-cell and B-cell epitopes in proteins encoded by HIV-1, HIV-2 and SIVMAC and the conservation of these sites between strains.
    Zvelebil MJ; Sternberg MJ; Cookson J; Coates AR
    FEBS Lett; 1988 Dec; 242(1):9-21. PubMed ID: 2462515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of broadly reactive continuous antigenic determinants of simian immunodeficiency virus glycoproteins.
    Miller MA; Murphey-Corb M; Montelaro RC
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1153-64. PubMed ID: 1380262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.